Back to 
Woodline Partners LP
Woodline Partners LP
CUE
Showing 0 of 7 quarters
Position history for Woodline Partners LP's holdings in CUE BIOPHARMA INC
No. Woodline Partners exited its CUE (Cue Biopharma) position in Q4 2021. Its Q3 2021 13F listed 285,133 shares worth $4.2M. Woodline Partners first reported CUE in Q2 2020 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.